Skip to main content
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2003 Nov;74(11):1530–1535. doi: 10.1136/jnnp.74.11.1530

Serum lipids and memory in a population based cohort of middle age women

V Henderson 1, J Guthrie 1, L Dennerstein 1
PMCID: PMC1738219  PMID: 14617710

Abstract

Objective:To assess the relation between serum lipids and memory in a healthy middle age cohort of women.

Methods: For 326 women in the Melbourne Women's Midlife Health Project aged 52–63 years, serum lipids were measured annually, and memory was assessed during the eighth annual visit.

Results:There was a small but significant association between current low density lipoprotein cholesterol (LDL-C) concentrations and memory; for total cholesterol (TC) the association approached significance. Better memory was associated with positive changes in TC and LDL-C based on lipid measurements three years, but not six years, earlier. Memory performance was lowest among women in the lowest quartile of current LDL-C values and among women whose LDL-C levels declined over the previous three years. High density lipoprotein cholesterol (HDL-C) and triglyceride concentrations were unassociated with memory. The association between memory and TC and LDL-C was primarily related to immediate recall and not delayed recall performance on the word list task. Low cholesterol has been linked with depression, but lipid measures and self-rated mood were unrelated.

Conclusions:Higher serum concentrations of LDL-C, and relatively recent increases in TC and LDL-C concentrations, are associated with better memory in healthy middle age women. Possible cognitive effects of cholesterol reduction should be considered in future studies of lipid lowering agents.

Full Text

The Full Text of this article is available as a PDF (354.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Benton D. Do low cholesterol levels slow mental processing? Psychosom Med. 1995 Jan-Feb;57(1):50–53. doi: 10.1097/00006842-199501000-00008. [DOI] [PubMed] [Google Scholar]
  2. Brown S. L., Salive M. E., Harris T. B., Simonsick E. M., Guralnik J. M., Kohout F. J. Low cholesterol concentrations and severe depressive symptoms in elderly people. BMJ. 1994 May 21;308(6940):1328–1332. doi: 10.1136/bmj.308.6940.1328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Burger H. G., Dudley E. C., Hopper J. L., Shelley J. M., Green A., Smith A., Dennerstein L., Morse C. The endocrinology of the menopausal transition: a cross-sectional study of a population-based sample. J Clin Endocrinol Metab. 1995 Dec;80(12):3537–3545. doi: 10.1210/jcem.80.12.8530596. [DOI] [PubMed] [Google Scholar]
  4. Collie A., Shafiq-Antonacci R., Maruff P., Tyler P., Currie J. Norms and the effects of demographic variables on a neuropsychological battery for use in healthy ageing Australian populations. Aust N Z J Psychiatry. 1999 Aug;33(4):568–575. doi: 10.1080/j.1440-1614.1999.00570.x. [DOI] [PubMed] [Google Scholar]
  5. Dennerstein L., Lehert P., Burger H., Dudley E. Mood and the menopausal transition. J Nerv Ment Dis. 1999 Nov;187(11):685–691. doi: 10.1097/00005053-199911000-00006. [DOI] [PubMed] [Google Scholar]
  6. Dennerstein L., Lehert P., Dudley E., Guthrie J. Factors contributing to positive mood during the menopausal transition. J Nerv Ment Dis. 2001 Feb;189(2):84–89. doi: 10.1097/00005053-200102000-00003. [DOI] [PubMed] [Google Scholar]
  7. Dennerstein L., Smith A. M., Morse C., Burger H., Green A., Hopper J., Ryan M. Menopausal symptoms in Australian women. Med J Aust. 1993 Aug 16;159(4):232–236. doi: 10.5694/j.1326-5377.1993.tb137821.x. [DOI] [PubMed] [Google Scholar]
  8. Eggertsen G., Tegelman R., Ericsson S., Angelin B., Berglund L. Apolipoprotein E polymorphism in a healthy Swedish population: variation of allele frequency with age and relation to serum lipid concentrations. Clin Chem. 1993 Oct;39(10):2125–2129. [PubMed] [Google Scholar]
  9. Elias M. F., Beiser A., Wolf P. A., Au R., White R. F., D'Agostino R. B. The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort. Arch Neurol. 2000 Jun;57(6):808–813. doi: 10.1001/archneur.57.6.808. [DOI] [PubMed] [Google Scholar]
  10. Evans R. M., Emsley C. L., Gao S., Sahota A., Hall K. S., Farlow M. R., Hendrie H. Serum cholesterol, APOE genotype, and the risk of Alzheimer's disease: a population-based study of African Americans. Neurology. 2000 Jan 11;54(1):240–242. doi: 10.1212/wnl.54.1.240. [DOI] [PubMed] [Google Scholar]
  11. Friedewald W. T., Levy R. I., Fredrickson D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972 Jun;18(6):499–502. [PubMed] [Google Scholar]
  12. Haan M. N., Shemanski L., Jagust W. J., Manolio T. A., Kuller L. The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. JAMA. 1999 Jul 7;282(1):40–46. doi: 10.1001/jama.282.1.40. [DOI] [PubMed] [Google Scholar]
  13. Haley R. W., Dietschy J. M. Is there a connection between the concentration of cholesterol circulating in plasma and the rate of neuritic plaque formation in Alzheimer disease? Arch Neurol. 2000 Oct;57(10):1410–1412. doi: 10.1001/archneur.57.10.1410. [DOI] [PubMed] [Google Scholar]
  14. Howland D. S., Trusko S. P., Savage M. J., Reaume A. G., Lang D. M., Hirsch J. D., Maeda N., Siman R., Greenberg B. D., Scott R. W. Modulation of secreted beta-amyloid precursor protein and amyloid beta-peptide in brain by cholesterol. J Biol Chem. 1998 Jun 26;273(26):16576–16582. doi: 10.1074/jbc.273.26.16576. [DOI] [PubMed] [Google Scholar]
  15. Jick H., Zornberg G. L., Jick S. S., Seshadri S., Drachman D. A. Statins and the risk of dementia. Lancet. 2000 Nov 11;356(9242):1627–1631. doi: 10.1016/s0140-6736(00)03155-x. [DOI] [PubMed] [Google Scholar]
  16. Kunugi H., Takei N., Aoki H., Nanko S. Low serum cholesterol in suicide attempters. Biol Psychiatry. 1997 Jan 15;41(2):196–200. doi: 10.1016/S0006-3223(95)00672-9. [DOI] [PubMed] [Google Scholar]
  17. Lindberg G., Råstam L., Gullberg B., Eklund G. A. Low serum cholesterol concentration and short term mortality from injuries in men and women. BMJ. 1992 Aug 1;305(6848):277–279. doi: 10.1136/bmj.305.6848.277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lobo R. A., Granger L., Goebelsmann U., Mishell D. R., Jr Elevations in unbound serum estradiol as a possible mechanism for inappropriate gonadotropin secretion in women with PCO. J Clin Endocrinol Metab. 1981 Jan;52(1):156–158. doi: 10.1210/jcem-52-1-156. [DOI] [PubMed] [Google Scholar]
  19. Modai I., Valevski A., Dror S., Weizman A. Serum cholesterol levels and suicidal tendencies in psychiatric inpatients. J Clin Psychiatry. 1994 Jun;55(6):252–254. [PubMed] [Google Scholar]
  20. Morgan R. E., Palinkas L. A., Barrett-Connor E. L., Wingard D. L. Plasma cholesterol and depressive symptoms in older men. Lancet. 1993 Jan 9;341(8837):75–79. doi: 10.1016/0140-6736(93)92556-9. [DOI] [PubMed] [Google Scholar]
  21. Moroney J. T., Tang M. X., Berglund L., Small S., Merchant C., Bell K., Stern Y., Mayeux R. Low-density lipoprotein cholesterol and the risk of dementia with stroke. JAMA. 1999 Jul 21;282(3):254–260. doi: 10.1001/jama.282.3.254. [DOI] [PubMed] [Google Scholar]
  22. Muldoon M. F., Barger S. D., Ryan C. M., Flory J. D., Lehoczky J. P., Matthews K. A., Manuck S. B. Effects of lovastatin on cognitive function and psychological well-being. Am J Med. 2000 May;108(7):538–546. doi: 10.1016/s0002-9343(00)00353-3. [DOI] [PubMed] [Google Scholar]
  23. Muldoon M. F., Ryan C. M., Matthews K. A., Manuck S. B. Serum cholesterol and intellectual performance. Psychosom Med. 1997 Jul-Aug;59(4):382–387. doi: 10.1097/00006842-199707000-00008. [DOI] [PubMed] [Google Scholar]
  24. Notkola I. L., Sulkava R., Pekkanen J., Erkinjuntti T., Ehnholm C., Kivinen P., Tuomilehto J., Nissinen A. Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology. 1998;17(1):14–20. doi: 10.1159/000026149. [DOI] [PubMed] [Google Scholar]
  25. Paganini-Hill A., Henderson V. W. The effects of hormone replacement therapy, lipoprotein cholesterol levels, and other factors on a clock drawing task in older women. J Am Geriatr Soc. 1996 Jul;44(7):818–822. doi: 10.1111/j.1532-5415.1996.tb03740.x. [DOI] [PubMed] [Google Scholar]
  26. Petersen R. C., Smith G. E., Waring S. C., Ivnik R. J., Tangalos E. G., Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999 Mar;56(3):303–308. doi: 10.1001/archneur.56.3.303. [DOI] [PubMed] [Google Scholar]
  27. Refolo L. M., Pappolla M. A., LaFrancois J., Malester B., Schmidt S. D., Thomas-Bryant T., Tint G. S., Wang R., Mercken M., Petanceska S. S. A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease. Neurobiol Dis. 2001 Oct;8(5):890–899. doi: 10.1006/nbdi.2001.0422. [DOI] [PubMed] [Google Scholar]
  28. Rockwood Kenneth, Kirkland Susan, Hogan David B., MacKnight Chris, Merry Heather, Verreault René, Wolfson Christina, McDowell Ian. Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people. Arch Neurol. 2002 Feb;59(2):223–227. doi: 10.1001/archneur.59.2.223. [DOI] [PubMed] [Google Scholar]
  29. Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med. 1999 Jan 14;340(2):115–126. doi: 10.1056/NEJM199901143400207. [DOI] [PubMed] [Google Scholar]
  30. Selkoe D. J. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev. 2001 Apr;81(2):741–766. doi: 10.1152/physrev.2001.81.2.741. [DOI] [PubMed] [Google Scholar]
  31. Shelley J. M., Green A., Smith A. M., Dudley E., Dennerstein L., Hopper J., Burger H. Relationship of endogenous sex hormones to lipids and blood pressure in mid-aged women. Ann Epidemiol. 1998 Jan;8(1):39–45. doi: 10.1016/s1047-2797(97)00123-3. [DOI] [PubMed] [Google Scholar]
  32. Swan G. E., LaRue A., Carmelli D., Reed T. E., Fabsitz R. R. Decline in cognitive performance in aging twins. Heritability and biobehavioral predictors from the National Heart, Lung, and Blood Institute Twin Study. Arch Neurol. 1992 May;49(5):476–481. doi: 10.1001/archneur.1992.00530290058012. [DOI] [PubMed] [Google Scholar]
  33. Taffe J., Dennerstein L. Retrospective self-report compared with menstrual diary data prospectively kept during the menopausal transition. Climacteric. 2000 Sep;3(3):183–191. doi: 10.1080/13697130008500099. [DOI] [PubMed] [Google Scholar]
  34. Vaughan C. J., Delanty N. Neuroprotective properties of statins in cerebral ischemia and stroke. Stroke. 1999 Sep;30(9):1969–1973. doi: 10.1161/01.str.30.9.1969. [DOI] [PubMed] [Google Scholar]
  35. Vermeulen A., Verdonck L. Sex hormone concentrations in post-menopausal women. Clin Endocrinol (Oxf) 1978 Jul;9(1):59–66. doi: 10.1111/j.1365-2265.1978.tb03572.x. [DOI] [PubMed] [Google Scholar]
  36. Wardle J., Rogers P., Judd P., Taylor M. A., Rapoport L., Green M., Nicholson Perry K. Randomized trial of the effects of cholesterol-lowering dietary treatment on psychological function. Am J Med. 2000 May;108(7):547–553. doi: 10.1016/s0002-9343(00)00330-2. [DOI] [PubMed] [Google Scholar]
  37. Wolozin B., Kellman W., Ruosseau P., Celesia G. G., Siegel G. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol. 2000 Oct;57(10):1439–1443. doi: 10.1001/archneur.57.10.1439. [DOI] [PubMed] [Google Scholar]
  38. Yaffe Kristine, Barrett-Connor Elizabeth, Lin Feng, Grady Deborah. Serum lipoprotein levels, statin use, and cognitive function in older women. Arch Neurol. 2002 Mar;59(3):378–384. doi: 10.1001/archneur.59.3.378. [DOI] [PubMed] [Google Scholar]
  39. Yeagle P. L. Modulation of membrane function by cholesterol. Biochimie. 1991 Oct;73(10):1303–1310. doi: 10.1016/0300-9084(91)90093-g. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES